Literature DB >> 191456

Physical properties of isolated complexes of human and bovine A-I apolipoproteins with L-alpha-dimyristoyl phosphatidylcholine.

A Jonas, D J Krajnovich, B W Patterson.   

Abstract

Human or bovine A-I apolipoproteins in solution form complexes with sonicated L-alpha-dimirystoyl phosphatidylcholine at 23 and 37 degrees, but not at 8 degrees, suggesting a strong dependence of the interaction on the physical state of the lipid (phase transition temperature 23 degrees). Complexes were isolated by gel filtration on a Sepharose 4B column and were subsequently analyzed for protein and lipid content, molecular weight, and physical state of the lipid portion. The average stoichiometry of all complexes, regardless of the initial concentrations or ratios of protein and lipid, was constant: 90 +/- 20 mol of phospholipid/mol of protein monomer, suggesting a highly cooperative interaction. Sedimentation equilibrium experiments indicated homogeneous macromolecular preparations and gave molecular weights around 235,000 (+/- 15%) for the complexes, with the human and bovine apo-A-I proteins contributing 77,000 (+/- 10%), i.e. about three protein subunits per complex. The lipid portion of the complexes retained some characteristics of a bilayer: it had a broad phase transition with a midpoint at 25.5 degrees as reported by the fluorescence polarization of the lipophilic probe diphenylhexatriene. Above the phase transition temperature the mobility of the phospholipids in the complexes with both apo-A-I proteins was considerably decreased relative to the pure L-alpha-dimyristoyl phosphatidylcholine dispersion; below the phase transition temperature the opposite was true, i.e. the protein fluidized the lipids. The results indicate that apol-A-I proteins interact stoichiometrically with L-alpha-dimyristoyl phosphatidylcholine vesicles above the gel to liquid-crystalline transition temperature of the lipid, promoting the destruction of vesicles and the formation of well defined particles of the general size of high density serum lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191456

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Interaction of plasma high density lipoprotein HDL2b (d 1.063-1.100 g/ml) with single-bilayer liposomes of dimyristoylphosphatidylcholine.

Authors:  A V Nichols; E L Gong; T M Forte; P J Blanche
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

2.  Ganglioside embedded in reconstituted lipoprotein binds cholera toxin with elevated affinity.

Authors:  Daniel A Bricarello; Emily J Mills; Jitka Petrlova; John C Voss; Atul N Parikh
Journal:  J Lipid Res       Date:  2010-05-14       Impact factor: 5.922

Review 3.  High density lipoprotein structure-function and role in reverse cholesterol transport.

Authors:  Sissel Lund-Katz; Michael C Phillips
Journal:  Subcell Biochem       Date:  2010

Review 4.  High density lipoprotein exchange reactions.

Authors:  J Loeb; G Dawson
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

5.  Thermotropic phase transition in soluble nanoscale lipid bilayers.

Authors:  Ilia G Denisov; Mark A McLean; Andrew W Shaw; Yelena V Grinkova; Stephen G Sligar
Journal:  J Phys Chem B       Date:  2005-08-18       Impact factor: 2.991

6.  Large disk intermediate precedes formation of apolipoprotein A-I-dimyristoylphosphatidylcholine small disks.

Authors:  Keng Zhu; Gregory Brubaker; Jonathan D Smith
Journal:  Biochemistry       Date:  2007-05-03       Impact factor: 3.162

7.  Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.

Authors:  H J Pownall; A Hu; A M Gotto; J J Albers; J T Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

Review 8.  Structural Insights into High Density Lipoprotein: Old Models and New Facts.

Authors:  Valentin Gogonea
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.